This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Hemovent GMBH raised $5.2mm in its Series B financing from undisclosed institutional and strategic investors. The company has developed the Mobybox self-contained, fully integrated extracorporeal membrane oxygenation /extracorporeal life support system that can support or replace heart and lung function in the event of cardiac and/or respiratory failure. Funding from the round will help Hemovent gain FDA approval for the device, expected later this year.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?